These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11683424)

  • 1. Statins and bone: myth or reality?
    Edwards CJ; Russell RG; Spector TD
    Calcif Tissue Int; 2001 Aug; 69(2):63-6. PubMed ID: 11683424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins as modulators of bone formation.
    Edwards CJ; Spector TD
    Arthritis Res; 2002; 4(3):151-3. PubMed ID: 12010563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anabolic effects of statin and beta-blocker on bone metabolism].
    Taguchi M; Takeuchi Y
    Clin Calcium; 2004 Dec; 14(12):89-94. PubMed ID: 15577180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statins and osteoporosis].
    Svejda P
    Vnitr Lek; 2006 Dec; 52(12):1190-3. PubMed ID: 17299913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and bone morphogenetic proteins: new pathways in bone formation.
    Edwards CJ
    Ann Acad Med Singap; 2002 Mar; 31(2):245-7. PubMed ID: 11957568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and bone metabolism.
    Horiuchi N; Maeda T
    Oral Dis; 2006 Mar; 12(2):85-101. PubMed ID: 16476028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of pleiotropic effects of statins in dementia.
    Crisby M
    Acta Neurol Scand Suppl; 2006; 185():115-8. PubMed ID: 16866920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG CoA reductase inhibitors and the skeleton: a comprehensive review.
    Bauer DC
    Osteoporos Int; 2003 Jun; 14(4):273-82. PubMed ID: 12736772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal effects of statins.
    Yaturu S
    Endocr Pract; 2003; 9(4):315-20. PubMed ID: 14561578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.
    Liu J; Zhu LP; Yang XL; Huang HL; Ye DQ
    Bone; 2013 May; 54(1):151-6. PubMed ID: 23388418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibitors and the risk of fractures.
    Meier CR; Schlienger RG; Kraenzlin ME; Schlegel B; Jick H
    JAMA; 2000 Jun; 283(24):3205-10. PubMed ID: 10866867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins, fracture risk, and bone remodeling.
    Luisetto G; Camozzi V
    J Endocrinol Invest; 2009; 32(4 Suppl):32-7. PubMed ID: 19724164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins: under investigation for increasing bone mineral density and augmenting fracture healing.
    Tang QO; Tran GT; Gamie Z; Graham S; Tsialogiannis E; Tsiridis E; Linder T; Tsiridis E
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1435-63. PubMed ID: 18808306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management.
    Coons JC
    Ann Pharmacother; 2002 Feb; 36(2):326-30. PubMed ID: 11847956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of HMG-CoA reductase inhibitors (statins) on bone mineral density.
    Funkhouser HL; Adera T; Adler RA
    J Clin Densitom; 2002; 5(2):151-8. PubMed ID: 12110758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase.
    Maciejak A; Leszczynska A; Warchol I; Gora M; Kaminska J; Plochocka D; Wysocka-Kapcinska M; Tulacz D; Siedlecka J; Swiezewska E; Sojka M; Danikiewicz W; Odolczyk N; Szkopinska A; Sygitowicz G; Burzynska B
    BMC Biotechnol; 2013 Aug; 13():68. PubMed ID: 24128347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and osteoporosis: can these lipid-lowering drugs also bolster bones?
    Cruz AC; Gruber BL
    Cleve Clin J Med; 2002 Apr; 69(4):277-8, 280-2, 287-8. PubMed ID: 11996199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and application of statins as a novel effective therapeutic approach against Acanthamoeba infections.
    Martín-Navarro CM; Lorenzo-Morales J; Machin RP; López-Arencibia A; García-Castellano JM; de Fuentes I; Loftus B; Maciver SK; Valladares B; Piñero JE
    Antimicrob Agents Chemother; 2013 Jan; 57(1):375-81. PubMed ID: 23114753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linköping University Medical Dissertation No. 1033. Following the mevalonate pathway to bone heal alley.
    Skoglund B
    Acta Orthop Suppl; 2007 Dec; 78(328):3-22. PubMed ID: 18283564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.